Correlations between atazanavir C<sub>trough </sub>and hyperbilirubinemia: a case report

Correlations between atazanavir C<sub>trough </sub>and hyperbilirubinemia: a case report

<p>Abstract</p> <p>Introduction</p> <p>Hyperbilirubinemia is a common side effect of the antiretroviral agent atazanavir but is generally reversible upon discontinuation of treatment. We used therapeutic drug monitoring to investigate the occurrence of hyperbilirubinemi...

Full description

Bibliographic Details
Main Authors:	Gulminetti Roberto, Novati Stefano, Uglietti Alessia, Maserati Renato
Format:	Article
Language:	English
Published:	BMC 2009-12-01
Series:	Journal of Medical Case Reports
Online Access:	http://www.jmedicalcasereports.com/content/3/1/9307

Similar Items

Study of atazanavir-induced hyperbilirubinemia among HIV patients on second-line anti-retroviral therapy
by: K Ravi, et al.
Published: (2020-01-01)

Hyperbilirubinemia in atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele
by: Panagopoulos P, et al.
Published: (2017-06-01)

Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
by: Naidoo A, et al.
Published: (2017-08-01)

Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients: is it time to revise atazanavir dosages?
by: Cristina Gervasoni, et al.
Published: (2015-01-01)

Antenatal Atazanavir: A Retrospective Analysis of Pregnancies Exposed to Atazanavir
by: Miriam Samuel, et al.
Published: (2014-01-01)

European source and sink areas of CO<sub>2</sub> retrieved from Lagrangian transport model interpretation of combined O<sub>2</sub> and CO<sub>2</sub> measurements at the high alpine research station Jungfraujoch
by: D. Brunner, et al.
Published: (2011-08-01)

Parametrized Analysis and Multi-Objective Optimization of Supercritical CO<sub>2</sub> (S-CO<sub>2</sub>) Power Cycles Coupled with Parabolic Trough Collectors
by: Lei Sun, et al.
Published: (2020-04-01)

Severe Skin Rash Associated with Atazanavir
by: Andrew Walkty, et al.
Published: (2009-01-01)

Role of atazanavir in the treatment of HIV infection
by: Pablo Rivas, et al.
Published: (2008-12-01)

Relationships between Serum Levels of Atazanavir and Renal Toxicity or Lithiasis
by: C. I. Marinescu, et al.
Published: (2015-01-01)

Correlation between Prolonged Hyperbilirubinemia and Serum Zinc Level in Term Neonates
by: Mousa Ahmadpour-kacho, et al.
Published: (2019-11-01)

Correlation between serum vitamin D level and neonatal indirect hyperbilirubinemia
by: Shahrokh Mehrpisheh, et al.
Published: (2018-05-01)

Baseline Amino Acid Substitutions in the NS5A ISDR and PKR Binding Domain of Hepatitis C and Different Fibrosis Levels and Levels of Development of Hepatocellular Carcinoma in Patients Treated with DAAs
by: Stefania Paolucci, et al.
Published: (2020-02-01)

Prospective evaluation of bone markers, parathormone and 1,25-(OH)<sub>2 </sub>vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz
by: Focà Emanuele, et al.
Published: (2012-02-01)

Correlation between cord blood bilirubin level and incidence of hyperbilirubinemia in term newborns
by: Rudy Satrya, et al.
Published: (2009-12-01)

PLANNING AND EVALUATION OF BIOEQUIVALENCE STUDIES OF ATAZANAVIR PRODUCTS
by: N. E. Uvarova, et al.
Published: (2018-12-01)

The strategy of pharmaceutical patent protection: the case of atazanavir
by: Carla Cristina de Freitas da Silveira, et al.
Published: (2016-03-01)

Correlation between neonatal hyperbilirubinemia and vitamin D levels: A meta-analysis.
by: Jiayu Huang, et al.
Published: (2021-01-01)

Investigation of a Novel CO<sub>2</sub> Transcritical Organic Rankine Cycle Driven by Parabolic Trough Solar Collectors
by: Evangelos Bellos, et al.
Published: (2021-08-01)

Conflicting effects of atazanavir therapy on atherosclerotic risk factors in stable HIV patients: A randomized trial of regimen switch to atazanavir.
by: Joshua A Beckman, et al.
Published: (2017-01-01)

Alkaline phosphatase and neonatal hyperbilirubinemia – correlations and cutoff values
by: Vlad Dima, et al.
Published: (2020-09-01)

Sub-Auroral, Mid-Latitude, and Low-Latitude Troughs during Severe Geomagnetic Storms
by: Alexander Karpachev
Published: (2021-02-01)

Atmospheric histories and growth trends of C<sub>4</sub>F<sub>10</sub>, C<sub>5</sub>F<sub>12</sub>, C<sub>6</sub>F<sub>14</sub>, C<sub>7</sub>F<sub>16</sub> and C<sub>8</sub>F<sub>18</sub>
by: R. F. Weiss, et al.
Published: (2012-05-01)

Global emission estimates and radiative impact of C<sub>4</sub>F<sub>10</sub>, C<sub>5</sub>F<sub>12</sub>, C<sub>6</sub>F<sub>14</sub>, C<sub>7</sub>F<sub>16</sub> and C<sub>8</sub>F<sub>18</sub>
by: R. G. Prinn, et al.
Published: (2012-08-01)

Hereditary hyperbilirubinemias
by: Radlović Nedeljko
Published: (2014-01-01)

Correlation between transcutaneous bilirubin estimation and total serum bilirubin estimation in neonatal hyperbilirubinemia
by: Avijit Mandal, et al.
Published: (2018-01-01)

Correlation between transcutaneous bilirubin estimation and total serum bilirubin estimation in neonatal hyperbilirubinemia
by: Mahmood Dhahir Al-Mendalawi
Published: (2018-01-01)

The Chiral 1:2 Adduct (<i>S</i>)<sub>S</sub>(<i>S</i>)<sub>C</sub>(−)<sub>589</sub>-Ethyl 2-Phenylbutyl Sulphide-Mercury (II) Chloride:(−)<sub>589</sub>[(<i>S</i>)<sub>S</sub>(<i>S</i>)<sub>C</sub>-Et(2-PhBu)S.(HgCl<sub>2</sub>)<sub>2</sub>]. Stereoselective Synthesis, Asymmetric Oxidation, Crystal and Molecular Structure and Circular Dichroism Spectra
by: Paolo Biscarini, et al.
Published: (2020-07-01)

Anthocyanins and Their C<sub>6</sub>-C<sub>3</sub>-C<sub>6</sub> Metabolites in Humans and Animals
by: Wilhelmina Kalt
Published: (2019-11-01)

Atazanavir Crystal–Induced Chronic Granulomatous Interstitial Nephritis
by: Vipin Varghese, et al.
Published: (2020-07-01)

Liver Profile of Atazanavir/Ritonavir in Pregnant Albino Rats
by: Elias Adikwu, et al.
Published: (2019-10-01)

Optimization of 100 MW<sub>e</sub> Parabolic-Trough Solar-Thermal Power Plants Under Regulated and Deregulated Electricity Market Conditions
by: Jorge M. Llamas, et al.
Published: (2019-10-01)

Development, Validation and Statistical Correlation of RP–LC Methods for Determination of Atazanavir Sulfate in Capsule Dosage Form
by: A. Behera, et al.
Published: (2012-01-01)

Association between rooming-in policy and neonatal hyperbilirubinemia
by: Ken-Hsyuan Shan, et al.
Published: (2019-04-01)

Antioxidant Potential of Aqueous Dispersions of Fullerenes C<sub>60</sub>, C<sub>70</sub>, and Gd@C<sub>82</sub>
by: Ivan V. Mikheev, et al.
Published: (2021-05-01)

Generalized Correlation of Binary Interaction Parameters in Cubic Equations of State for Hydrocarbon/cO<sub>2</sub>, Hydrocarbon/H<sub>2</sub>s and CO<sub>2</sub>/H<sub>2</sub>s Systems
by: O. Barrios, et al.
Published: (2011-04-01)

LC<sub>50</sub> Determination and Phenotypic Analysis of Three C<sub>6</sub>-C<sub>1</sub> and C<sub>6</sub>-C<sub>3</sub> Bio-phenols Using Zebrafish (Danio rerio) Model
by: D.R. Merchan Arenas, et al.
Published: (2018-05-01)

Comparison of the Ionic Liquid Crystal Phase of [C<sub>12</sub>C<sub>1</sub>im][BF<sub>4</sub>] and [C<sub>12</sub>C<sub>1</sub>im]Cl by Atomistic MD Simulations
by: Giacomo Saielli
Published: (2020-03-01)

Correlation between hyperbilirubinemia in term infants and developmental delay in 2-4 year-old children
by: Rocky Wilar, et al.
Published: (2010-06-01)

Is It Conjugated or Not? The Theoretical and Experimental Electron Density Map of Bonding in <i>p</i>-CH<sub>3</sub>CH<sub>2</sub>COC<sub>6</sub>H<sub>4</sub>-C≡C-C≡C-<i>p</i>-C<sub>6</sub>H<sub>4</sub>COCH<sub>3</sub>CH<sub>2</sub>
by: Przemysław Starynowicz, et al.
Published: (2020-09-01)